The France Journal
SEE OTHER BRANDS

The top news stories from France

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on July 25, 2025

Enkrypt AI Releases Agent Risk Taxonomy to Secure Autonomous AI Systems

Enkrypt AI Releases Agent Risk Taxonomy to Secure Autonomous AI Systems

Agent Risk Taxonomy delivers actionable guidance for managing autonomous AI risks in real-world enterprise environments. BOSTON, MA, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- Enkrypt AI today announced the release of its **Agent Risk Taxonomy …

Aircraft Accessory Gearbox Market to be at $2.1 Billion Opportunity, and Share Growing at CAGR of 6.3% by 2033

Aircraft Accessory Gearbox Market to be at $2.1 Billion Opportunity, and Share Growing at CAGR of 6.3% by 2033

The Market is experiencing significant growth, driven by the increasing production of commercial and military aircraft, advancements in engine technology. WILMINGTON, DE, UNITED STATES, July 25, 2025 /⁨EINPresswire.com⁩/ -- The aircraft accessory gearbox …

Influence Society améliore les services hôteliers en tirant parti de l’IA agentique grâce à l'intégration Webflow MCP

Influence Society améliore les services hôteliers en tirant parti de l’IA agentique grâce à l'intégration Webflow MCP

Webflow MCP change la donne pour les hôteliers et restaurateurs souhaitant orchestrer sans effort la création, la publication et l'automatisation de contenu PARIS, FRANCE, July 25, 2025 /⁨EINPresswire.com⁩/ -- Influence Society, le principal partenaire …

Vallourec Completes the Disposal of Serimax

Vallourec Completes the Disposal of Serimax

VALLOUREC COMPLETES THE DISPOSAL OF SERIMAX Meudon (France), July 25th, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces today that it has finalized on July 24th the disposal process of Serimax, Vallourec’s subsidiary …

VALLOUREC FINALISE LA CESSION DE SERIMAX

VALLOUREC FINALISE LA CESSION DE SERIMAX

VALLOUREC FINALISE LA CESSION DE SERIMAX Meudon (France), le 25 juillet 2025 – Vallourec, leader mondial des solutions tubulaires premium sans soudure, annonce avoir finalisé, le 24 juillet, la cession de Serimax, filiale de Vallourec spécialisée dans les …

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) PARIS, France, July 25, 2025 – 08:00 a.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the …

Vallourec Second Quarter 2025 Results

Vallourec Second Quarter 2025 Results

Meudon (France), July 25th, 2025 Vallourec, a world leader in premium tubular solutions, announces today its results for the second quarter 2025. The Board of Directors of Vallourec SA, meeting on July 24th 2025, approved the Group's second quarter 2025 …

Vallourec : Résultats du Second Trimestre 2025

Vallourec : Résultats du Second Trimestre 2025

Meudon (France), le 25 juillet 2025 Vallourec, un leader mondial de solutions tubulaires premium, annonce aujourd’hui ses résultats du deuxième trimestre 2025. Le Conseil d’Administration de Vallourec SA, réuni le 24 juillet 2025, a arrêté les comptes …

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction treatment significantly improved MRD negativity benefit …

Communiqué de presse : Sarclisa de Sanofi approuvé dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe

Communiqué de presse : Sarclisa de Sanofi approuvé dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe

Sarclisa de Sanofi approuvé dans l’UE pour le traitement du myélome multiple nouvellement diagnostiqué chez les patients éligibles à une greffe Approbation fondée sur l’étude de phase 3 GMMG-HD7, qui a montré que l’ajout de Sarclisa au traitement d’ …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions